Novabay Announces Neutrophase Available in Spray Pump
NovaBay Pharmaceuticals (NYSE: NBY) today announced that it has received 510k clearance from the Food and Drug Administration to market NeutroPhase® Skin and Wound Cleanser under widened indications including the moistening and debriding of graft and donor sites. Concurrently, the FDA cleared NeutroPhase to be administered through a new convenient spray pump.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.